F

Forge Nano

Develops nanocoatings to enhance manufacturing performance

Software Engineer 1

Full-Time
$90k - $95k/yr
Entry
Bachelor's
Thornton, CO, USA
In PersonOn-site position; up to 15% travel may be required.
Software EngineeringDesktop Application Development
No H1B Sponsorship
US Citizenship Required

About the job

Requirements
  • A bachelor's degree in Computer Science, Computer Engineering, Industrial Automation, Electrical Engineering, Software Engineering, or a related technical discipline, or equivalent practical experience.
  • Zero to two years of relevant software engineering experience, including internships, co-op assignments, academic projects, research projects, or other applicable experience.
  • Experience with at least one object-oriented programming language; C# is preferred.
  • Strong problem-solving, analytical, and troubleshooting skills.
  • Strong written and verbal communication skills.
  • Excellent attention to detail and organizational skills.
  • Ability to work effectively in a collaborative, cross-functional team environment.
  • Ability to learn complex industrial software systems and equipment operations.
  • This is an on-site position in office, laboratory, and semiconductor equipment manufacturing environments; required personal protective equipment may include safety glasses, protective gloves, steel-toe footwear, lab coat, and hard hat in designated operational areas.
  • Strict adherence to company policies, operating procedures, safety requirements, and site-specific protocols is required.
  • Frequent standing, walking, reaching, and use of hands to operate computers, tools, laboratory equipment, and production systems are required; occasional work near moving mechanical equipment may be required.
  • All candidates must be a U.S. citizen or permanent resident.
Responsibilities
  • Implement and test well-defined software features, enhancements, and bug fixes using C#, .NET, WPF, database technologies, and control logic under technical guidance.
  • Develop unit tests and participate in software verification activities to ensure product quality and reliability.
  • Troubleshoot software defects, document findings, and support corrective actions.
  • Participate in code reviews, design reviews, and team development activities.
  • Maintain software requirements, design documentation, test plans, release notes, and other engineering records.
  • Use Git, issue tracking systems, and standard software development practices to support project execution.
  • Communicate project progress, technical challenges, and risks to project stakeholders and engineering leadership.
  • Support equipment integration, laboratory testing, commissioning, and software deployment activities.
  • Learn and operate the company's Windows-based semiconductor equipment Human Machine Interface (HMI).
  • Develop a working understanding of equipment hardware, subsystems, controls architecture, and process workflows.
  • Assist with validation and verification activities associated with software updates and equipment functionality.
  • Execute manual test cases and document test results to support product releases.
  • Collaborate with software developers and equipment engineers to identify, troubleshoot, and resolve technical issues.
  • Participate in system startup activities and support continuous improvement initiatives.
  • Observe and document software and hardware interactions to support accurate operating procedures and technical documentation.
  • Capture screenshots, operating workflows, configuration procedures, and troubleshooting information.
  • Identify undocumented functionality, workflow gaps, usability concerns, and opportunities for improvement.
  • Assist in developing release notes and revision-controlled documentation.
  • Support the creation and maintenance of technical documentation used by engineering, manufacturing, and customer-facing teams.
  • Contribute to efforts that improve software quality, user experience, and operational efficiency.
  • Travel up to 15% to support customer site activities, system commissioning, equipment startup, maintenance, troubleshooting, training, and other business needs.
  • Frequently stand, walk, reach, and use hands to operate computers, tools, laboratory equipment, and production systems; regularly communicate and collaborate across engineering, manufacturing, and operational functions.
Desired Qualifications
  • Exposure to C#, .NET, WPF, database applications, or Windows desktop software development.
  • Familiarity with PLC programming, industrial automation systems, or industrial communication networks.
  • Experience using Git, Agile development methodologies, and issue tracking tools.
  • Exposure to laboratory, manufacturing, robotics, semiconductor, or hardware integration environments.
  • Experience supporting automated equipment, controls systems, or industrial software applications.
  • Understanding of software testing methodologies and quality assurance practices.

About the company

Forge Nano develops and deploys Atomic Armor, a nanocoating that enhances manufactured products, especially in semiconductors and powders. Atomic Armor is deposited at the nanoscale onto surfaces or powders, improving battery life, fuel stability, medicine shelf life, and wafer durability. The company differentiates itself with a scalable, industry-grade coating platform proven across diverse materials, building on its lab-to-commercial scaling heritage from the University of Colorado ALD group. Its goal is to help manufacturers boost performance and sustainability by applying durable nanoscale coatings at scale.

Company Size

51-200

Company Stage

Series D

Total Funding

$450.8M

Headquarters

Thornton, Colorado

Founded

2011

Get referred to Forge Nano

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 22, 2026 registration became effective, clearing a major hurdle for the NASDAQ listing.
  • Samsung SDI invested $20 million and committed conditional cell purchases starting in 2028.
  • DOE-backed Morrisville expansion targets 3 GWh annually and more than 250 North Carolina jobs.

What critics are saying

  • ATII merger still needs October 16, 2026 shareholder approval; failure blocks public listing.
  • Morrisville gigafactory starts in 2028, leaving execution risk before any scaled battery revenue.
  • Forge Nano’s $40 million 2026 revenue target is small against a $300 million buildout.

What makes Forge Nano unique

  • Atomic Armor spans semiconductors, batteries, and pharma, extending Forge Nano beyond one market.
  • Samsung SDI partnership gives Forge Nano manufacturing know-how and a 2028 procurement path.
  • Nanexa JDA on September 22, 2026 validates ALD coatings in GMP pharmaceutical equipment.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Disability Insurance
  • Life Insurance
  • Paid Holidays
  • Paid Vacation
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-3%
Yahoo Finance
Oct 16th, 2026
Archimedes Tech SPAC II shareholders approve Forge Nano merger, Nasdaq debut as "NANO" imminent

Shareholders of Archimedes Tech SPAC Partners II Co. (ATII), a Nasdaq-listed special purpose acquisition company, approved its business combination with Forge Nano, Inc. at an Extraordinary General Meeting on October 16, 2026. The deal is expected to close in the coming days, subject to remaining closing conditions. The combined company will operate as Forge Nano Holdings, Inc. and plans to trade on Nasdaq under the ticker symbols "NANO" for shares and "NANOW" for warrants. Forge Nano is a US semiconductor equipment and advanced materials company. It uses Atomic Layer Deposition technology for AI-era chip manufacturing and defence battery applications. ATII raised $230 million in its February 2025 IPO. Its earlier SPAC merged with SoundHound AI, Inc. in April 2022.

PCI Magazine
Oct 13th, 2026
Forge Nano Raises $20 million in Series A Funding

Forge Nano, formerly PneumatiCoat Technologies, a Colorado-based startup that has innovated a breakthrough technology to enable precision nano-coatings at scale for manufacturing, has closed a Series A investment of $20 million to expand its manufacturing capacity.

Ohsem.me
Sep 22nd, 2026
Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines.

Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines. 22/09/2026 * Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa's broad portfolio of proprietary and partnered PharmaShell(R) programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell(R) drug delivery platform and its portfolio of proprietary and partnered programs. Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale production across the Nanexa's PharmaShell(R) portfolio. The infrastructure and process know-how potentially gained through the collaboration will find its use in multiple PharmaShell(R)-enabled therapeutic programs. Nanexa's PharmaShell(R) technology is designed to enable long-acting formulations through precisely engineered nanoscale coatings using the ALD technology. The platform can be applied to a broad range of active pharmaceutical ingredients, including small molecules and biologics, across multiple therapeutic areas. The collaboration combines Nanexa's expertise in drug delivery and pharmaceutical development with Forge Nano's capabilities in industrial ALD process development and equipment engineering. The broad potential of the platform is further illustrated by NEX-22, Nanexa's proprietary GLP-1 programme, where preclinical and clinical proof of concept have demonstrated the feasibility of achieving a once-monthly depot formulation. "This agreement demonstrates the potential to apply Forge Nano's ALD expertise to pharmaceutical manufacturing, where process control, repeatability, and scalability are critical," said Paul Lichty, Chief Executive Officer of Forge Nano. "Through this collaboration, we intend to establish flexible manufacturing capabilities that can support a wide range of PharmaShell(R)-enabled products as they progress towards clinical and commercial scale." The agreement builds on the companies' existing relationship and is intended to create a pathway towards increased manufacturing capacity as Nanexa's proprietary and partnered PharmaShell(R) programs progress through development. These include Nanexa's internal product portfolio, its license agreement with Moderna and other undisclosed collaborations with pharmaceutical companies. Any future commercialization of PharmaShell(R)-enabled products remain subject to successful development, regulatory approvals and other factors. "This collaboration is an important milestone, and the timing of the partnership is well aligned with our project portfolio and provides a clear path towards increased manufacturing capacity as our projects advance" said David Westberg, CEO of Nanexa. "As our programs progress and interest from pharmaceutical partners continues to increase, access to scalable manufacturing solutions becomes increasingly important. Forge Nano brings substantial expertise in industrial ALD technology and will help position Nanexa for future commercial manufacturing needs," said Mårten Rooth, CTO of Nanexa. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. ABOUT NANEXA Nanexa is bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation. The company's proprietary PharmaShell(R) platform is a unique drug delivery system that enables a high drug load, thus low injection volume, creating a new generation of 'super generic' formulations that will provide greater convenience and reduce costs in the treatment of conditions such as metabolic diseases like type 2 diabetes and obesity, hematology/oncology, cardiovascular disorders, psychiatry, and many others. Nanexa develops its own products and also has collaboration agreements with several pharma companies, including the latest license and option agreement with Moderna. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected] 02/07/2026 18/08/2014 13/05/2026 27/04/2026 30/04/2026 Discover more Deploy Enterprise Cloud Latest gadgets

GlobeNewswire
Sep 22nd, 2026
Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines.

Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines. September 22, 2026 08:47 ET | Source: Forge Nano * Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa's broad portfolio of proprietary and partnered PharmaShell(R) programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell(R) drug delivery platform and its portfolio of proprietary and partnered programs. Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale production across the Nanexa's PharmaShell(R) portfolio. The infrastructure and process know-how potentially gained through the collaboration will find its use in multiple PharmaShell(R)-enabled therapeutic programs. Nanexa's PharmaShell(R) technology is designed to enable long-acting formulations through precisely engineered nanoscale coatings using the ALD technology. The platform can be applied to a broad range of active pharmaceutical ingredients, including small molecules and biologics, across multiple therapeutic areas. The collaboration combines Nanexa's expertise in drug delivery and pharmaceutical development with Forge Nano's capabilities in industrial ALD process development and equipment engineering. The broad potential of the platform is further illustrated by NEX-22, Nanexa's proprietary GLP-1 programme, where preclinical and clinical proof of concept have demonstrated the feasibility of achieving a once-monthly depot formulation. "This agreement demonstrates the potential to apply Forge Nano's ALD expertise to pharmaceutical manufacturing, where process control, repeatability, and scalability are critical," said Paul Lichty, Chief Executive Officer of Forge Nano. "Through this collaboration, we intend to establish flexible manufacturing capabilities that can support a wide range of PharmaShell(R)-enabled products as they progress towards clinical and commercial scale." The agreement builds on the companies' existing relationship and is intended to create a pathway towards increased manufacturing capacity as Nanexa's proprietary and partnered PharmaShell(R) programs progress through development. These include Nanexa's internal product portfolio, its license agreement with Moderna and other undisclosed collaborations with pharmaceutical companies. Any future commercialization of PharmaShell(R)-enabled products remain subject to successful development, regulatory approvals and other factors. "This collaboration is an important milestone, and the timing of the partnership is well aligned with our project portfolio and provides a clear path towards increased manufacturing capacity as our projects advance" said David Westberg, CEO of Nanexa. "As our programs progress and interest from pharmaceutical partners continues to increase, access to scalable manufacturing solutions becomes increasingly important. Forge Nano brings substantial expertise in industrial ALD technology and will help position Nanexa for future commercial manufacturing needs," said Mårten Rooth, CTO of Nanexa. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. ABOUT NANEXA Nanexa is bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation. The company's proprietary PharmaShell(R) platform is a unique drug delivery system that enables a high drug load, thus low injection volume, creating a new generation of 'super generic' formulations that will provide greater convenience and reduce costs in the treatment of conditions such as metabolic diseases like type 2 diabetes and obesity, hematology/oncology, cardiovascular disorders, psychiatry, and many others. Nanexa develops its own products and also has collaboration agreements with several pharma companies, including the latest license and option agreement with Moderna. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected]

Associated Press
Sep 17th, 2026
Forge Nano expands AI partnership with Voltaiq for battery development at new 3 GWh gigafactory

Forge Nano has expanded its partnership with Voltaiq to integrate artificial intelligence across its battery operations. The collaboration will embed Voltaiq's Battery Intelligence platform throughout Forge Nano's US battery development and production facilities. As Forge Nano scales towards high-volume manufacturing, it will use AI to accelerate development, improve quality and provide faster insights. The company recently broke ground on a 3 GWh/year gigafactory in Morrisville, North Carolina, targeting high-performance defence and aerospace applications. Voltaiq's enterprise software will support the entire product lifecycle, enabling engineers to rapidly identify manufacturing anomalies, quality issues and equipment problems during production. The platform unifies electrochemical, materials and process data, giving engineers visibility into performance differences. Forge Nano is merging with Archimedes Tech SPAC Partners II Co.